Veterinary medicines update

February 2016
Veterinary Record: Journal of the British Veterinary Association;Feb2016, Vol. 178 Issue 6, p132
Academic Journal
The article provides an update for veterinary surgeons on changes to marketing authorisations for veterinary medicines in Great Britain and on other relevant issues as of February 2016. Topics covered include a table that shows where a public assessment report should become available for a product, the dosage regimen in cattle, and diluent for suspension for injection for Muscovy ducks.


Related Articles

  • Veterinary medicines update.  // Veterinary Record: Journal of the British Veterinary Association;1/2/2016, Vol. 178 Issue 1, p11 

    The article presents an update on the changes in marketing authorisations that can affect the prescribing decisions of veterinary surgeons in Great Britain as of January 2016. It presents a table listing the new marketing authorisations which include Ataxxa, Bupredine Multidose and Milprazin. It...

  • Patients large and small: role of the pharmacist in veterinary medicine. Wick, Jeannette Y.; Zanni, Guido R. // Journal of the American Pharmacists Association: JAPhA;May/Jun2004, Vol. 44 Issue 3, p319 

    Discusses in detail the role of the pharmacist in veterinary medicine. History of veterinary medicine; Overview of the veterinary drug approval process; Problems being encountered by small animal veterinarians.

  • Veterinary medicines: product update. Saville, Vivienne // Veterinary Record: Journal of the British Veterinary Association;5/4/2013, Vol. 172 Issue 18, p469 

    The article offers an update on the changes to marketing authorisations for veterinary medications in Great Britain. A variation to a marketing authorisation has been approved for the drug Versifel CVR. A table summarizing the new marketing authorizations issued in March 2013 is presented which...

  • More human drugs crossing over to the veterinary market. LoBuono, Charlotte // Drug Topics;10/11/2004, Vol. 148 Issue 19, p24 

    This article reports on the utilization of human drugs as medications for animals. According to the article, many manufacturers of veterinary drugs in the U.S. are looking to agents already licensed for human use to fill their pipeline of new products. Elaine Lust, an assistant professor of...

  • Drug rulings to affect licensing. Long, Jonathan; Riley, Jonathan // Farmers Weekly;10/7/2005, Vol. 143 Issue 15, p15 

    Reports that anyone supplying drugs under the suitably qualified persons (SQP) category would need new qualifications to register in Great Britain according to Steve Dean, CEO of the Vet Medicines Directorate. Expected date of implementation of rules governing the supply of veterinary...

  • Prescribing and dispensing of veterinary medicines. Hern, J.C. // Veterinary Record: Journal of the British Veterinary Association;1/10/2004, Vol. 154 Issue 2, p60 

    Reports on the progress of the proposed implementation of prescription veterinary drugs in Great Britain. Guidelines for advertising; Supply issues addressed by the government.

  • A clearer picture on medicines?  // Veterinary Record: Journal of the British Veterinary Association;9/11/2004, Vol. 155 Issue 11, p313 

    Comments on the drafts proposals launched by the Veterinary Medicines Directorate (VMD) on how it intends to implement new European Union rules on how veterinary medicines might become classified and distributed in Great Britain. Efforts by the VMD to recast medicines legislation in the country...

  • WHAT THE VET ORDERED. GALLAGHER, JULIE // SN: Supermarket News;5/14/2012, Vol. 60 Issue 20, p31 

    The article reports on the implications of the legislation called the Fairness to Pet Owners Act of 2011 on retail pharmacies and veterinary clinics in the U.S. The American Veterinary Medical Association (AVMA) has serious concerns about the possible mandate because the majority of pharmacists...

  • Medicines and the DTI.  // Veterinary Record: Journal of the British Veterinary Association;6/11/2005, Vol. 156 Issue 24, p753 

    Focuses on views and insights of the author on the issue concerning medicines and the Department of Trade and Industry (DTI) in the U.S. Details on the implementation of the Competition Commission's recommendations on the supply of prescription-only veterinary medicines (POMS); Concern expressed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics